366
Participants
Start Date
October 19, 2021
Primary Completion Date
May 31, 2028
Study Completion Date
May 31, 2028
ASP1570
Oral tablet
pembrolizumab
Intravenous Infusion
Trifluridine + Tipiracil
Oral Administration
Bevacizumab
Intravenous Infusion
Docetaxel
Intravenous Infusion
Oxaliplatin
Intravenous Infusion
Leucovorin
Intravenous Infusion
5-Fluorouracil
Intravenous Infusion
Irinotecan
Intravenous Infusion
Pemetrexed
Intravenous Infusion
Carboplatin
Intravenous Infusion
RECRUITING
Columbia University, New York
RECRUITING
UPMC Hillman Cancer Center, Pittsburgh
RECRUITING
American Oncology Partners, Bethesda
RECRUITING
Florida Cancer Specialist & Research Institute Sarasota, Sarasota
ACTIVE_NOT_RECRUITING
SCRI Oncology Partners, Nashville
RECRUITING
University of Kentucky Medical Center MCC-CRO, Lexington
RECRUITING
University Hospitals Cleveland Medical Center, Cleveland
RECRUITING
University of Wisconsin Clinical Science Center, Madison
RECRUITING
University of Chicago, Chicago
RECRUITING
Nebraska Methodist Hospital, Omaha
RECRUITING
Mary Crowley Research Center, Dallas
RECRUITING
California Research Institute, Los Angeles
RECRUITING
USC/Norris Comprehensive Cancer Center, Los Angeles
RECRUITING
Providence Medical Foundation, Fullerton
WITHDRAWN
Atlantic Health System/Morristown Medical Center, Morristown
RECRUITING
Sun Yat-Sen University Cancer Center, Guangzhou
RECRUITING
Second Affiliated Hospital Zhejiang University School of Medicine (SAHZU), Hangzhou
RECRUITING
Beijing Cancer Hospital, Beijing
RECRUITING
Shanghai East Hospital, Shanghai
RECRUITING
FR33007, Besançon
RECRUITING
Site FR33002, Bordeaux
RECRUITING
FR33008, Paris
RECRUITING
FR33001, Poitiers
RECRUITING
FR33005, Saint-Herblain
RECRUITING
FR33009, Toulouse
RECRUITING
Site FR33004, Villejuif
RECRUITING
National Cancer Center Hospital, Chuo-ku
RECRUITING
Cancer Institute Hospital Of JFCR, Koto-ku
RECRUITING
Site PR1601, Río Piedras
ACTIVE_NOT_RECRUITING
KR82002, Seoul
RECRUITING
Site ES34005, A Coruña, Barcelona
RECRUITING
Site ES34004, Avda
RECRUITING
Site ES34002, Madrid
RECRUITING
ES34008, Málaga
RECRUITING
Site ES34007, Málaga
RECRUITING
Site ES34006, Pozuelo de Alarcón
RECRUITING
ES34003, Santiago de Compostela
RECRUITING
Aichi Cancer Center, Chikusa-ku, Nagoya-City
RECRUITING
National Cancer Center Hospital East, Kashiwa
RECRUITING
Kanagawa Cancer Center, Yokohama
RECRUITING
Shizuoka Cancer Center, Sunto-gun
Merck Sharp & Dohme LLC
INDUSTRY
Astellas Pharma Global Development, Inc.
INDUSTRY